TCIM
ASMB icon

TIAA CREF Investment Management’s Assembly Biosciences ASMB Stock Holding History

TIAA CREF Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$751K Sell
3,176
-3,287
-51% -$832K ﹤0.01% 2435
2018
Q4 		$1.75M Buy
6,463
+1,270
+24% +$367K ﹤0.01% 2031
2018
Q3 		$2.31M Sell
5,193
-2,100
-29% -$984K ﹤0.01% 2053
2018
Q2 		$3.43M Sell
7,293
-451
-6% -$238K ﹤0.01% 1871
2018
Q1 		$4.57M Buy
7,744
+1,716
+28% +$1.06M ﹤0.01% 1606
2017
Q4 		$3.27M Buy
6,028
+1,922
+47% +$870K ﹤0.01% 1863
2017
Q3 		$1.72M Buy
4,106
+352
+9% +$108K ﹤0.01% 2247
2017
Q2 		$930K Buy
+3,754
New +$1.06M ﹤0.01% 2582
2016
Q2 		– Sell
-4,081
Closed -$246K – 3154
2016
Q1 		$246K Hold
4,081
– – ﹤0.01% 2951
2015
Q4 		$368K Buy
4,081
+261
+7% +$28.4K ﹤0.01% 2974
2015
Q3 		$438K Buy
3,820
+1,345
+54% +$237K ﹤0.01% 2919
2015
Q2 		$572K Buy
+2,475
New +$478K ﹤0.01% 2925
2013
Q3 		– Sell
-49
Closed -$7K – 3093
2013
Q2 		$7K Buy
+49
New +$7.68K ﹤0.01% 3102

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TIAA CREF Investment Management's ASMB Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Assembly Biosciences (ASMB) stake by 51% in Q1 2019, selling an estimated $832K and leaving 3,176 shares worth $751K. The position accounts for ﹤0.01% of the portfolio, ranked #2435.

TIAA CREF Investment Management first reported a position in ASMB in Q2 2013 and has held it in 13 quarters since. The position peaked at $4.57M in Q1 2018. 103 funds tracked by Wall St. Rank hold ASMB as of Q1 2019.

  • TIAA CREF Investment Management held 3,176 shares of Assembly Biosciences worth $751K as of Q1 2019.
  • TIAA CREF Investment Management sold 3,287 Assembly Biosciences shares in Q1 2019, an estimated $832K.
  • Assembly Biosciences made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2435 holding.
  • TIAA CREF Investment Management first reported a position in Assembly Biosciences in Q2 2013 and has held it in 13 quarters since.
  • TIAA CREF Investment Management's Assembly Biosciences position peaked at $4.57M in Q1 2018.
  • 103 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.